Co-Authors
This is a "connection" page, showing publications co-authored by Stephanie Jones and Shabir Madhi.
Connection Strength
2,636
-
Immunogenicity of seven-valent pneumococcal conjugate vaccine administered at 6, 14 and 40 weeks of age in South African infants. PLoS One. 2013; 8(8):e72794.
Score: 0,453
-
Potential for Maternally Administered Vaccine for Infant Group B Streptococcus. N Engl J Med. 2023 Jul 20; 389(3):215-227.
Score: 0,225
-
Antepartum SARS-CoV-2 infection and adverse birth outcomes in South African women. J Glob Health. 2022 Dec 03; 12:05050.
Score: 0,215
-
Active Intrapartum SARS-CoV-2 Infection and Pregnancy Outcomes. Am J Perinatol. 2022 12; 39(S 01):S42-S48.
Score: 0,214
-
Correlation of dried blood spots and plasma for quantification of Immunoglobulin (IgG) against Receptor binding domain and full length spike protein of SARS-CoV-2. J Virol Methods. 2022 02; 300:114394.
Score: 0,201
-
Association of Group B Streptococcus (GBS) Serum Serotype-Specific Anticapsular Immunoglobulin G Concentration and Risk Reduction for Invasive GBS Disease in South African Infants: An Observational Birth-Cohort, Matched Case-Control Study. Clin Infect Dis. 2021 09 07; 73(5):e1170-e1180.
Score: 0,198
-
Prevalence of Congenital Cytomegalovirus Infection and Associated Risk of In Utero Human Immunodeficiency Virus (HIV) Acquisition in a High-HIV Prevalence Setting, South Africa. Clin Infect Dis. 2019 10 30; 69(10):1789-1796.
Score: 0,174
-
Lessons learnt from enrolment and follow up of pregnant women and their infants in clinical trials in South Africa, a low-middle income country. Vaccine. 2015 Nov 25; 33(47):6406-12.
Score: 0,131
-
Acquisition of Streptococcus pneumoniae in South African children vaccinated with 7-valent pneumococcal conjugate vaccine at 6, 14 and 40 weeks of age. Vaccine. 2015 Jan 29; 33(5):628-34.
Score: 0,124
-
Influenza vaccination of pregnant women and protection of their infants. N Engl J Med. 2014 Sep 04; 371(10):918-31.
Score: 0,122
-
Effect of breastfeeding on immunogenicity of oral live-attenuated human rotavirus vaccine: a randomized trial in HIV-uninfected infants in Soweto, South Africa. Bull World Health Organ. 2014 Apr 01; 92(4):238-45.
Score: 0,117
-
One-year post-primary antibody persistence and booster immune response to a DTaP-IPV//PRP~T vaccine (Pentaxim) given at 18 - 19 months of age in South African children primed at 6, 10 and 14 weeks of age with the same vaccine. S Afr Med J. 2011 Nov 28; 101(12):879-83.
Score: 0,100
-
Long-term immunogenicity and efficacy of a 9-valent conjugate pneumococcal vaccine in human immunodeficient virus infected and non-infected children in the absence of a booster dose of vaccine. Vaccine. 2007 Mar 22; 25(13):2451-7.
Score: 0,070
-
An outbreak of infection due to severe acute respiratory corona virus-2 in a neonatal unit from a low and middle income setting. Front Pediatr. 2022; 10:933982.
Score: 0,053
-
Fetal Transfer of Human Metapneumovirus-Neutralizing Antibodies Is Reduced From Mothers Living With HIV-1. J Pediatric Infect Dis Soc. 2022 Apr 07.
Score: 0,051
-
Immunogenicity and safety of different dosing schedules of trivalent inactivated influenza vaccine in pregnant women with HIV: a randomised controlled trial. Lancet HIV. 2020 02; 7(2):e91-e103.
Score: 0,044
-
Rubella seroprevalence in pregnant women living with and without HIV in Soweto, South Africa. Int J Infect Dis. 2020 Feb; 91:255-260.
Score: 0,044
-
Duration of Infant Protection Against Influenza Illness Conferred by Maternal Immunization: Secondary Analysis of a Randomized Clinical Trial. JAMA Pediatr. 2016 09 01; 170(9):840-7.
Score: 0,035
-
Influenza vaccination of pregnant women protects them over two consecutive influenza seasons in a randomized controlled trial. Expert Rev Vaccines. 2016 08; 15(8):1055-62.
Score: 0,034
-
Kinetics of Hemagglutination-Inhibiting Antibodies Following Maternal Influenza Vaccination Among Mothers With and Those Without HIV Infection and Their Infants. J Infect Dis. 2015 Dec 15; 212(12):1976-87.
Score: 0,032